InnovAge Holding Corp. Announces $5.0 Million Share Repurchase Program
10 Giugno 2024 - 2:00PM
InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”)
announced today that its Board of Directors has approved a share
repurchase program (the “Program”) that authorizes the Company to
repurchase up to $5.0 million of its common stock.
Share repurchases under the Program may be made from time to
time on the open market, including pursuant to the safe harbor
provided under Rule 10b-18 of the Securities Exchange Act of 1934,
in privately negotiated transactions, or in any other manner that
complies with the applicable securities law, including through the
use of Rule 10b5-1 trading plans. The timing of purchases and
number of shares repurchased under the Program will depend upon a
variety of factors including the Company’s stock price, trading
volume, corporate and regulatory requirements, and market
conditions. The Company is not obligated to purchase any shares
under the Program and the Program may be suspended or discontinued
at any time without notice.
About InnovAge
InnovAge is a market leader in managing the care of high-cost,
frail, predominantly dual-eligible seniors. Our mission is to
enable seniors to age independently in their own homes for as long
as safely possible. Our patient-centered care model is designed to
improve the quality of care our participants receive, while
reducing over-utilization of high-cost care settings. InnovAge
believes its healthcare model is one in which all
constituencies — participants, their families, providers and
government payors — “win.” As of March 31, 2024, InnovAge
served approximately 6,820 participants across 19 centers in six
states. https://www.innovage.com.
Investor Contact:
Ryan Kubotarkubota@myinnovage.com
Media Contact:
Lara Hazenfieldlhzenfield@innovage.com
Forward-Looking Statements - Safe
Harbor
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as “intend,” “believe,”
“expect,” “will” and similar references to future
periods. Forward-looking statements may be identified by the
fact that they do not relate strictly to historical or current
facts. Examples of forward-looking statements include, among
others, statements regarding the Company’s Program, including the
timing and amount of any share repurchases made pursuant to the
Program, if any, and the effects of any of the foregoing on our
future results of operations or financial conditions.
You should not place undue reliance on our forward-looking
statements. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of
which are outside of our control. Our actual results may differ
materially from those indicated in the forward-looking statements.
Important factors that could cause our actual results and financial
condition to differ materially from those indicated in the
forward-looking statements include, among others, the viability of
our growth strategy, including our ability to obtain licenses to
open de novo centers; our ability to attract new participants and
retain existing participants; the results of periodic inspections,
reviews, audits and investigations under the federal and state
government programs; the adverse impact of inspections, reviews,
audits investigations, legal proceedings, enforcement actions and
litigation; and the impact on our business from ongoing
macroeconomic challenges, including labor shortages and inflation.
For a detailed discussion of the risks and uncertainties that could
affect our actual results, please refer to the risk factors
identified in our SEC reports, including, but not limited to our
most recent Annual Report on Form 10-K and subsequent Quarterly
Reports on Form 10-Q, in each case, as filed with the SEC.
Any forward-looking statement made by the Company in this press
release is based only on information currently available to us and
speaks only as of the date on which it is made. Except as required
by law, we undertake no obligation to publicly update any
forward-looking statement, whether written or oral, that may be
made from time to time, whether as a result of new information,
future developments or otherwise.
Grafico Azioni InnovAge (NASDAQ:INNV)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni InnovAge (NASDAQ:INNV)
Storico
Da Feb 2024 a Feb 2025